glp-1 produced by for Weight Loss and Diabetes GLP-1: Actions on Beta-cell Mass

Any decision to start GLP-1 medications should be based on a comprehensive evaluation of the individual's overall health status, personal medical history, and treatment goals

For companies engaged in compounding of GLP-1 drug products, the warnings signal a need to reassess labeling, advertising, and promotional strategies

In human beings, GIPR is a receptor found to be expressed in the endothelial cells of some blood vessels, the pancreas, as well as in the heart [24]

2023 [cited 2023 Apr 22]

Quick Answer: GLP-1 receptor agonists can generally be used safely in patients with Hashimoto's thyroiditis, with no absolute contraindication, though individualised assessment and thyroid function monitoring are essential